Dr. Sherman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
88 Central Park West
New York, NY 10023Phone+1 917-570-2906Fax+1 212-496-5109
Education & Training
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1969 - 1971
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1969
Certifications & Licensure
IL State Medical License 1970 - Present
NJ State Medical License 1987 - Present
NY State Medical License 1973 - 2026
FL State Medical License 2000 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III) Start of enrollment: 2009 Dec 01
Publications & Presentations
PubMed
- 13 citationsPredictors of Response and Survival in Locally Advanced Adenocarcinoma of the Pancreas Following Neoadjuvant GTX with or Without Radiation TherapyWilliam H. Sherman, Elizabeth M. Hecht, David Leung, Kyung Chu
The Oncologist. 2018-01-01 - 6 citationsFludarabine in the Treatment of Refractory Chronic Inflammatory Demyelinating Neuropathies.Megan Leitch, William H. Sherman, Thomas H. Brannagan
Journal of Clinical Neuromuscular Disease. 2015-09-01 - 38 citationsNeoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable pancreati...William H. Sherman, Kyung Chu, John A. Chabot, John D. Allendorf, Beth Schrope
Cancer. 2015-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
